Copyright © 2000 by the European Society of Cardiology.
Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study
a Department of Clinical Pharmacology, University of Groningen, Groningen, The Netherlands
b Department of Cardiology, Academic Hospital, Groningen, The Netherlands
c Department of Nephrology, Academic Hospital, Groningen, The Netherlands
d Department of Medical Informatics, Erasmus University, Rotterdam, The Netherlands
e Julius Center for Patient Oriented Research, University Medical Center, Utrecht, The Netherlands
Received April 11, 2000; accepted April 12, 2000
Abstract
Aim To assess the value of microalbuminuria as an indicator of increased cardiovascular risk in a non-diabetic population.
Methods and Results 7579 non-diabetic subjects were studied with ages ranging from 28 to 75 years selected from a population based cohort. Using computerized Minnesota coding, ischaemic electrocardiographic abnormalities were divided into three categories: infarct patterns, major ischaemia, and minor ischaemia. Urinary albumin excretion was measured as the mean of two 24-h urine collections. Cardiovascular risk indicators were defined as an age above 60 years, male sex, hypertension, hypercholesterolaemia, smoking, obesity and a positive cardiovascular family history. Microalbuminuria was associated with age, sex, blood pressure, serum cholesterol, serum glucose, body mass index and all three categories of electrocardiographic abnormalities. In a multivariate model, adjusted for established cardiovascular risk indicators, microalbuminuria was independently associated with infarct patterns (OR [95% CI] 1·61 [1·122·32]), major ischaemia (OR 1·43 [1·081·91]) and minor ischaemia (OR 1·32 [1·031·68]).
Conclusions The independent association between microalbuminuria and ischaemic electrocardiographic abnormalities suggests that microalbuminuria has additional value to conventional risk indicators in predicting cardiovascular disease in non-diabetics. Assessment of microalbuminuria could be an instrument to identify those at an increased risk for coronary vascular disease in an early stage.
Key Words: Microalbuminuria, electrocardiography, coronary heart disease, non-diabetic
f1 Correspondence: G. F. H. Diercks, MD, Department of Clinical Pharmacology, University of Groningen, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands.
References
- Shepherd J, Cobbe SM, Ford I. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:13011307
[Abstract/Free Full Text] - Br Med J. 1985;291:97104
[Abstract/Free Full Text] - Grundy SM, Balady GJ, Criqui MH. Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. Circulation. 1997;95:23292331
[Free Full Text] - Heller RF, Chinn S, Tunstall Pedoe HD, Rose G. How well can we predict coronary heart disease? Findings from the United Kingdom Heart Disease Prevention Project. Br Med J. 1984;288:14091411
[Abstract/Free Full Text] - Mogensen CE, Keane WF, Bennett PH. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 1995;346:10801084[CrossRef][Web of Science][Medline]
- Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41:736741[Abstract]
- Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J. 1990;300:297300
[Abstract/Free Full Text] - Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet. 1988;ii:530533
- Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis. 1990;10:727731
[Abstract/Free Full Text] - de Bruyne MC, Kors JA, Hoes AW. Diagnostic interpretation of electrocardiograms in population-based research: computer program, research physician, or cardiologist? The Rotterdam Study. J Clin Epidemiol. 1997;50:947952[CrossRef][Web of Science][Medline]
- Cullen K, Stenhouse NS, Wearne KL, Cumpston GN. Electrocardiograms and 13 year cardiovascular mortality in Busselton study. Br Heart J. 1982;47:209212
[Abstract/Free Full Text] - Knutsen R, Knutsen SF, Curb JD, Reed DM, Kautz JA, Yano K. The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program. J Clin Epidemiol. 1988;41:293302[CrossRef][Web of Science][Medline]
- Sutherland SE, Gazes PC, Keil JE, Gilbert GE, Knapp RG. Electrocardiographic abnormalities and 30-year mortality among white and black men of the Charleston Heart Study. Circulation. 1993;88:26852692
[Abstract/Free Full Text] - Gerstein HC, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S. Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. Diabetes Care. 1996;19:12251228[Abstract]
- Kors JA, van HG, Wu J, Zhang Z, Prineas RJ, van Bemmel BJ. Validation of a new computer program for Minnesota coding. J Electrocardiol. 1996;29:8388
- Willems JL, Abreu-Lima C, van Bemmel BJ. The diagnostic performance of computer programs for the interpretation of electrocardiograms. N Engl J Med. 1991;325:17671773[Abstract]
- Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens. 1996;14:223228[Web of Science][Medline]
- Cassel J, Heyen S, Bartel AG. Incidence of coronary heart disease by ethnic group, social class, and sex. Arch Intern Med. 1971;128:901906
[Abstract/Free Full Text] - Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Predicting coronary heart disease in middle-aged and older persons. The Framington study. J Am Med Assoc. 1977;238:497499
[Abstract/Free Full Text] - Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152:5664
[Abstract/Free Full Text] - Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:13721379
[Abstract/Free Full Text] - Myers RH, Kiely DK, Cupples LA, Kannel WB. Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J. 1990;120:963969[CrossRef][Web of Science][Medline]
- Cirillo M, Senigalliesi L, Laurenzi M. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med. 1998;158:19331939
[Abstract/Free Full Text] - Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem. 1992;38:18021808
[Abstract/Free Full Text] - Lancet. 1996;348:13391342[CrossRef][Web of Science][Medline]
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801809[CrossRef][Medline]
- Deckert T, Feldt RB, Borch JK, Jensen T, Kofoed EA. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989;32:219226[CrossRef][Web of Science][Medline]
- Jensen JS, Borch JK, Jensen G, Feldt RB. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci Colch. 1995;88:629633[Medline]
- Stehouwer CD, Fischer HR, van KA, Polak BC, Donker AJ. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes. 1995;44:561564[Abstract]
- Zenere BM, Arcaro G, Saggiani F, Rossi L, Muggeo M, Lechi A. Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care. 1995;18:975982[Abstract]
- Gruden G, Cavallo PP, Bazzan M, Stella S, Vuolo A, Pagano G. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes. 1994;43:426429[Abstract]
- Yokoyama H, Hoyer PE, Hansen PM. Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes. 1997;46:18751880[Abstract]
- Castellot JJJ, Addonizio ML, Rosenberg R, Karnovsky MJ. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J Cell Biol. 1981;90:372379
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
M. E. Suliman, M. I. Yilmaz, J. J. Carrero, A. R. Qureshi, M. Saglam, O. M. Ipcioglu, M. Yenicesu, M. Tong, O. Heimburger, P. Barany, et al. Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 976 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Weir Microalbuminuria and Cardiovascular Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 581 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sonmez, A. O. Eskisar, D. Demir, M. V. Yazicioglu, B. Mutlu, Y. Dogan, A. Izgi, D. Mansuroglu, R. B. Bakal, O. H. Elonu, et al. Increased Urinary Albumin Excretion Rates Can Be a Marker of Coexisting Coronary Artery Disease in Patients with Peripheral Arterial Disease Angiology, January 1, 2006; 57(1): 15 - 20. [Abstract] [PDF] |
||||
![]() |
M. Cirillo, M. Laurenzi, M. Mancini, A. Zanchetti, and N. G. De Santo Low Muscular Mass and Overestimation of Microalbuminuria by Urinary Albumin/Creatinine Ratio Hypertension, January 1, 2006; 47(1): 56 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Montalescot and J.-P. Collet Preserving cardiac function in the hypertensive patient: why renal parameters hold the key Eur. Heart J., December 2, 2005; 26(24): 2616 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
E V Barnes, S Narain, A Naranjo, J Shuster, M S Segal, E S Sobel, A E Armstrong, B E Santiago, W H Reeves, and H B Richards High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk Lupus, August 1, 2005; 14(8): 576 - 582. [Abstract] [PDF] |
||||
![]() |
R. Pontremoli, G. Leoncini, M. Ravera, F. Viazzi, S. Vettoretti, E. Ratto, D. Parodi, C. Tomolillo, and G. Deferrari Microalbuminuria, Cardiovascular, and Renal Risk in Primary Hypertension J. Am. Soc. Nephrol., November 1, 2002; 13(90003): S169 - 172. [Abstract] [Full Text] |
||||
![]() |
G. F. H. Diercks, H. L. Hillege, A. d J. van Boven, J. A. Kors, H. J. G. M. Crijns, D. E. Grobbee, P. E. de Jong, and W. H. van Gilst Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1401 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease Vascular Medicine, November 1, 2001; 6(4): 257 - 264. [Abstract] [PDF] |
||||
![]() |
G.C. Viberti and S.M. Thomas Searching for new coronary heart disease risk factors Eur. Heart J., December 1, 2000; 21(23): 1905 - 1906. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







